Literature DB >> 27707505

Dose painting by numbers based on retrospectively determined recurrence probabilities.

Eric Grönlund1, Silvia Johansson2, Anders Montelius3, Anders Ahnesjö3.   

Abstract

BACKGROUND AND
PURPOSE: The aim of this study is to derive "dose painting by numbers" prescriptions from retrospectively observed recurrence volumes in a patient group treated with conventional radiotherapy for head and neck squamous cell carcinoma.
MATERIALS AND METHODS: The spatial relation between retrospectively observed recurrence volumes and pre-treatment standardized uptake values (SUV) from fluorodeoxyglucose positron emission tomography (FDG-PET) imaging was determined. Based on this information we derived SUV driven dose-response functions and used these to optimize ideal dose redistributions under the constraint of equal average dose to the tumor volumes as for a conventional treatment. The response functions were also implemented into a treatment planning system for realistic dose optimization.
RESULTS: The calculated tumor control probabilities (TCP) increased between 0.1-14.6% by the ideal dose redistributions for all included patients, where patients with larger and more heterogeneous tumors got greater increases than smaller and more homogeneous tumors.
CONCLUSIONS: Dose painting prescriptions can be derived from retrospectively observed recurrence volumes spatial relation to pre-treatment FDG-PET image data. The ideal dose redistributions could significantly increase the TCP for patients with large tumor volumes and large spread in SUV from FDG-PET. The results yield a basis for prospective studies to determine the clinical value for dose painting of head and neck squamous cell carcinomas.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dose painting; Dose painting by numbers; Dose painting optimization; FDG-PET/CT; Head and neck cancer

Mesh:

Substances:

Year:  2016        PMID: 27707505     DOI: 10.1016/j.radonc.2016.09.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine positron emission tomography.

Authors:  Robert Kosztyla; Srinivas Raman; Vitali Moiseenko; Stefan A Reinsberg; Brian Toyota; Alan Nichol
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

2.  Implications of the Harmonization of [18F]FDG-PET/CT Imaging for Response Assessment of Treatment in Radiotherapy Planning.

Authors:  Elisa Jiménez-Ortega; Raquel Agüera; Ana Ureba; Marcin Balcerzyk; Amadeo Wals-Zurita; Francisco Javier García-Gómez; Antonio Leal
Journal:  Tomography       Date:  2022-04-12

3.  Imaging science and development in modern high-precision radiotherapy.

Authors:  Daniela Thorwarth; Ludvig Muren
Journal:  Phys Imaging Radiat Oncol       Date:  2019-12-09

4.  Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI.

Authors:  E J Her; A Haworth; H M Reynolds; Y Sun; A Kennedy; V Panettieri; M Bangert; S Williams; M A Ebert
Journal:  Radiat Oncol       Date:  2020-07-13       Impact factor: 3.481

5.  Robust maximization of tumor control probability for radicality constrained radiotherapy dose painting by numbers of head and neck cancer.

Authors:  Eric Grönlund; Erik Almhagen; Silvia Johansson; Erik Traneus; Anders Ahnesjö
Journal:  Phys Imaging Radiat Oncol       Date:  2019-12-09

6.  Intrafractional motion models based on principal components in Magnetic Resonance guided prostate radiotherapy.

Authors:  Samuel Fransson; David Tilly; Anders Ahnesjö; Tufve Nyholm; Robin Strand
Journal:  Phys Imaging Radiat Oncol       Date:  2021-10-04

7.  Adaptive dose painting for prostate cancer.

Authors:  Emil Fredén; David Tilly; Anders Ahnesjö
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

8.  Impact of different biologically-adapted radiotherapy strategies on tumor control evaluated with a tumor response model.

Authors:  Araceli Gago-Arias; Beatriz Sánchez-Nieto; Ignacio Espinoza; Christian P Karger; Juan Pardo-Montero
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

Review 9.  Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy.

Authors:  Yaru Pang; Hui Wang; He Li
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.